Previous reports have shown that PIM1 overexpression increased ERK1/2 phosphorylation in prostate cancer cells [29], increased p38-MAPK activation by phosphorylation in Basophils [31], and increased activation of JNK in cardiomyocytes by PIM3 [32]. This evidence concerns the gene MAPK3 and prostate carcinoma.